Eledon Pharma announces resignation of Principal Accounting Officer, appoints Paul Little as successor

Eledon Pharmaceuticals, Inc.

Jon Kuwahara resigned as SVP, Finance & Administration and Principal Accounting Officer effective July 31, 2021.
Paul Little, current CFO and Principal Financial Officer, appointed as Principal Accounting Officer effective same date.
No family relationships or arrangements were disclosed in connection with the appointment.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Paul Little

Principal Accounting Officer

ELDN · Eledon Pharmaceuticals, Inc.

Effective: 2021-07-31
Filed: August 2, 2021, 7:59 PM ET

the Company’s Board of Directors appointed Paul Little as the Company’s Principal Accounting Officer, effective as of July 31, 2021.

Departed

Jon Kuwahara

Senior Vice President, Finance & Administration and Principal Accounting Officer

ELDN · Eledon Pharmaceuticals, Inc.

Effective: 2021-07-31
Successor: Paul Little
Filed: August 2, 2021, 7:59 PM ET

Effective July 31, 2021, Jon Kuwahara resigned as the Senior Vice President, Finance & Administration and Principal Accounting Officer of Eledon Pharmaceuticals, Inc. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Paul Little was appointed as Principal Accounting Officer at Eledon Pharmaceuticals, Inc..

Action: appointed
Role: Principal Accounting Officer

Exact text from the filing

the Company’s Board of Directors appointed Paul Little as the Company’s Principal Accounting Officer, effective as of July 31, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Jon Kuwahara resigned as Senior Vice President, Finance & Administration and Principal Accounting Officer at Eledon Pharmaceuticals, Inc..

Action: resigned
Role: Senior Vice President, Finance & Administration and Principal Accounting Officer

Exact text from the filing

Effective July 31, 2021, Jon Kuwahara resigned as the Senior Vice President, Finance & Administration and Principal Accounting Officer of Eledon Pharmaceuticals, Inc. (the “Company”).

View on SEC.gov

Eledon Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-21-039644

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.